Keywords: solvay, sees, dip, pharma, sales, belgian, pharmaceuticals
Solvay sees dip in 2004 pharma sales
Article | 07 March 2005
Belgian pharmaceuticals, chemicals and plastics group Solvay reported a 4% rise in total sales to 7.88 billion euros ($10.45 billion) for 2004 although, at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
